Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07247942 · ClinicalTrials.gov registry record · Phase 1
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
A Phase 1 study of Healthy Subjects (HS), sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT07247942: Completed Phase 1 study of Healthy Subjects (HS), sponsored by Wockhardt.
NCT07247942 is a Phase 1 study of Healthy Subjects (HS) that has completed, run by Wockhardt. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07247942, a Phase 1 study of Healthy Subjects (HS), has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
A Phase 1, Open-label Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion in Healthy Male Subjects
Primary Outcome
The primary PK outcome endpoints of zidebactam and total radioactivity derived from urine collections is the amount excreted in urine (Aeu).
Conditions Studied
Interventions
- DRUG zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hour
Study Locations (1)
Wisconsin
- Covance Clinical Research Unit Inc. 3402 Kinsman Boulevard Madison, Wisconsin 53704 USA - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2019-01-30 |
| Phase | Phase 1 |
What the finished NCT07247942 record still lists
NCT07247942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Healthy Subjects (HS) appearing as the primary indexed condition, and to 1 intervention - of which zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hour is the first listed.
NCT07247942 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07247942 about?
NCT07247942 is a clinical study titled "Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.". A Phase 1, Open-label Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion in Healthy Male Subjects
What is the current status of trial NCT07247942?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2017-12-13. Estimated completion is 2019-01-30.
What conditions does trial NCT07247942 study?
This clinical trial studies the following conditions: Healthy Subjects (HS).
What interventions are being tested in trial NCT07247942?
The interventions under investigation include: zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hour (DRUG).
Who is sponsoring clinical trial NCT07247942?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07247942 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07247942's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI